Fennec Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Fennec Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 9.73M	$ 6.51M	$ 3.33M	$ 1.68M	$ 1.53M
Gross Profit	$ 9.05M	$ 6.18M	$ 3.18M	$ 1.58M	-
EBIT	$ -1.77M	$ -1.01M	$ -4.62M	$ -5.25M	$ -6.11M
EBITDA	$ -1.70M	$ -939.00K	$ -4.55M	$ -5.18M	$ -6.11M
Net Income Common Stockholders	$ -2.68M	$ -1.87M	$ -5.44M	$ -6.05M	$ -6.86M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 13.27M	$ 12.40M	$ 14.96M	$ 18.39M	$ 23.77M
Total Assets	$ 26.86M	$ 19.03M	$ 19.44M	$ 21.82M	$ 26.94M
Total Debt	$ 29.73M	$ 24.72M	$ 24.68M	$ 24.66M	$ 24.90M
Net Debt	$ 16.46M	$ 12.32M	$ 9.72M	$ 6.27M	$ 1.13M
Total Liabilities	$ 38.49M	$ 29.56M	$ 29.16M	$ 29.16M	$ 29.51M
Stockholders Equity	$ -11.62M	$ -10.53M	$ -9.73M	$ -7.34M	$ -2.57M
Cash Flow	-
Free Cash Flow	$ -4.86M	-	$ -3.95M	$ -5.58M	$ -6.80M
Operating Cash Flow	$ -4.86M	-	$ -3.95M	$ -5.58M	$ -6.80M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 5.73M	-	$ 514.00K	$ 193.00K	$ 824.00K

Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History

Income Statement >

Fennec Pharmaceuticals Debt to Assets

Balance Sheet >

Fennec Pharmaceuticals Cash Flow

Cash Flow >

Fennec Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing